ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Novel Antibiotic To Solve the Antibiotic Crisis?

by Mary Beth Nierengarten • July 28, 2015

  • Tweet
  • Email
Print-Friendly Version

A new way of developing antibiotics using uncultivable soil bacterium is sparking interest with its potential to tackle an emerging public health problem posed by the rise of antibiotic resistance.

You Might Also Like

No related posts.

A novel antibiotic, called teixobactin, produced from bacteria in live dirt to treat mice infected with S. aureus or Streptococcus pneumonia reduced infection without adverse side effects, and, importantly, appears not to be susceptible to resistant bacteria.

The research was published earlier this year in Nature.

“The antibiotic seems to work against many Gram-positive bacteria including those resistant to antibiotics in current use,” said Gerry Wright, PhD, who is with the department of biochemistry and biomedical sciences at McMaster University in Hamilton, Ontario, Canada, who wrote a commentary that accompanied the study (Nature 2015;517:442-444).

In the study, the researchers used a new technique to cultivate rare taxa that included cultivation in situ. Using a multichannel miniaturized device they developed called the iChip, the investigators cultivated rare cells directly in their source environments. Among the 10,000 strains of bacteria screened, teixobactin was found to be the most promising candidate and in laboratory and mice studies showed excellent activity against Gram-positive pathogens such as Streptococcus (Strep) and Staphylococcus (Staph) infections.

Teixobactin is thought to work by inhibiting cell wall synthesis by binding to two precursors of bacterial cell-wall polymers—lipid II (peptidoglycan) and lipid II (cell wall teichoic acid).

Importantly, attempts to generate teixobactin-resistant mutants to susceptible Gram-positive bacteria were unsuccessful.

Emphasizing that finding an antibiotic in the lab is just the first step in the process to developing a new drug, Dr. Wright stressed that teixobactin still needs to undergo safety and efficacy tests. “Only time will tell if this compound will go the distance,” he said.

Filed Under: Online Exclusives Tagged With: antibiotics, research

You Might Also Like:

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Some Studies Predict a Shortage of Otolaryngologists. Do the Numbers Support Them?
    • Neurogenic Cough Is Often a Diagnosis of Exclusion
    • Complications for When Physicians Change a Maiden Name
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • Tympanoplasty Tips: Otology Experts Give Advice on the Procedure
    • How Treatment for Obstructive Sleep Apnea (OSA) Is Evolving to Give Patients a Better Night’s Sleep
    • Vestibular Schwannoma Position Relative to Internal Auditory Canal Helps Predict Postoperative Facial Function
    • Vocal Fold Lipoaugmentation Provides Long-Term Voice Improvements for Glottal Insufficiency
    • Upper Lateral Cartilage Mucosal Flap Enables the Successful Closure of Larger Septal Perforations

Polls

Do you think there will be a shortage of otolaryngologists in the next five to 10 years?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2022 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.